BEAM Beam Therapeutics Inc. Common Stock Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
02:12
Sep 10
Sep 10
r/wallstreetbets
Bought BEAM at 25 as good entry
The author bought BEAM because 25 is described as a usually good entry level for the stock. The rationale is purely a price-level/entry heuristic rather than a fundamental catalyst, and no explicit risk or time horizon is given.
BEAM
Beam Therapeutics Inc. Common Stock
Long
1ST
—
—
23:56
Apr 28
Apr 28
CNBC
Beam is too speculative, avoid.
Beam Therapeutics is a speculative, heavily shorted biotech with no earnings. Unless they have something that saves lives, move on.
BEAM
Beam Therapeutics Inc. Common Stock
Avoid
—
—
14:53
Feb 03
Feb 03
r/ValueInvesting
Gene editing data strong; BLA catalyst but safety/burn risk.
Author argues Beam Therapeutics has exceptionally strong clinical data, with risto-cel eliminating vaso-occlusive crises in 31 patients and BEAM-302 showing ~91% protein correction, plus $1.1B cash to reach a 2026 BLA filing. Catalysts include formalizing the risto-cel BLA package in 2026, longer-term BEAM-302 follow-up, and initial BEAM-301 data. Main risk is safety, highlighted by a patient death in the BEACON trial from conditioning toxicity, and a $450M annual burn that could require dilutive financing if regulatory delays occur.
BEAM
Beam Therapeutics Inc. Common Stock
Long
1ST
—
—
About BEAM Investor Commentary
Across the available history and selected sources, Buzzberg tracks BEAM (Beam Therapeutics Inc. Common Stock) across 8 sources: 4 bullish vs 0 bearish calls from 10 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 16 total trade ideas tracked. Past 7 days, before deduplication: 2 other directions. Latest voices: u/Valkyrie_Skuld, Jim Cramer, u/Significant-Pair-275.